Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease.
Ann Neurol. 2021 Jul;90(1):52-61. doi: 10.1002/ana.26073. Epub 2021 May 4.
Ann Neurol. 2021.
PMID: 33772855
Free PMC article.